» Articles » PMID: 39747250

MANF Overexpression Ameliorates Oxidative Stress-induced Apoptosis of Human Nucleus Pulposus Cells by Facilitating Mitophagy Through Promoting MFN2 Expression

Overview
Journal Sci Rep
Specialty Science
Date 2025 Jan 2
PMID 39747250
Authors
Affiliations
Soon will be listed here.
Abstract

Intervertebral disc degeneration (IDD) is a degenerative condition associated with impaired mitophagy. MANF has been shown to promote mitophagy in murine kidneys; however, its role in IDD remains unexplored. This study aimed to elucidate the mechanism by which MANF influences IDD development through the regulation of mitophagy. Human nucleus pulposus (NP) cells were exposed to tert-butyl hydroperoxide (TBHP) to establish an oxidative stress-induced cellular model. The expression levels of MANF in NP cells were quantified using quantitative real-time PCR (qPCR) and Western blotting. The impact of MANF on TBHP-induced NP cells was evaluated by assessing cell viability, apoptosis, and the levels of mitophagy-related proteins. The underlying mechanisms were further investigated using RNA-binding protein immunoprecipitation (RIP), dual-luciferase reporter assays, qPCR, and Western blotting. Results indicated that MANF expression was significantly downregulated in both IDD patients and TBHP-induced NP cells. Overexpression of MANF inhibited apoptosis, enhanced cell viability, and promoted mitophagy in TBHP-treated NP cells. MFN2 was identified as a downstream target of MANF, and MANF overexpression upregulated MFN2 expression in NP cells, whereas TBHP markedly suppressed MFN2 expression. Furthermore, knockdown of MFN2 partially reversed the effects of MANF overexpression on apoptosis, cell viability, and mitophagy in TBHP-treated NP cells. Collectively, these findings demonstrate that MANF overexpression enhances mitophagy by upregulating MFN2 expression, thereby mitigating oxidative stress-induced apoptosis in NP cells. These results provide novel insights into the pathogenesis of IDD.

References
1.
Kritschil R, Scott M, Sowa G, Vo N . Role of autophagy in intervertebral disc degeneration. J Cell Physiol. 2021; 237(2):1266-1284. PMC: 8866220. DOI: 10.1002/jcp.30631. View

2.
Risbud M, Shapiro I . Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2013; 10(1):44-56. PMC: 4151534. DOI: 10.1038/nrrheum.2013.160. View

3.
Mohd Isa I, Teoh S, Mohd Nor N, Mokhtar S . Discogenic Low Back Pain: Anatomy, Pathophysiology and Treatments of Intervertebral Disc Degeneration. Int J Mol Sci. 2023; 24(1). PMC: 9820240. DOI: 10.3390/ijms24010208. View

4.
Wang Y, Cheng H, Wang T, Zhang K, Zhang Y, Kang X . Oxidative stress in intervertebral disc degeneration: Molecular mechanisms, pathogenesis and treatment. Cell Prolif. 2023; 56(9):e13448. PMC: 10472537. DOI: 10.1111/cpr.13448. View

5.
Kang L, Liu S, Li J, Tian Y, Xue Y, Liu X . The mitochondria-targeted anti-oxidant MitoQ protects against intervertebral disc degeneration by ameliorating mitochondrial dysfunction and redox imbalance. Cell Prolif. 2020; 53(3):e12779. PMC: 7106957. DOI: 10.1111/cpr.12779. View